Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 117

1.

Exploring the neuropsychiatric spectrum using high-content functional analysis of single-cell signaling networks.

Lago SG, Tomasik J, van Rees GF, Ramsey JM, Haenisch F, Cooper JD, Broek JA, Suarez-Pinilla P, Ruland T, Auyeug B, Mikova O, Kabacs N, Arolt V, Baron-Cohen S, Crespo-Facorro B, Bahn S.

Mol Psychiatry. 2018 Jul 23. doi: 10.1038/s41380-018-0123-4. [Epub ahead of print]

PMID:
30038233
2.

Identification of AKT1 3'UTR variants in two Indian schizophrenia patients with poor executive functioning.

Chow TJ, Tee SF, Loh SY, Yong HS, Abu Bakar AK, Song SL, Tang PY.

Asian J Psychiatr. 2018 May 22;36:17-18. doi: 10.1016/j.ajp.2018.05.025. [Epub ahead of print] No abstract available.

PMID:
29864676
3.

Using coordinate-based meta-analyses to explore structural imaging genetics.

Janouschek H, Eickhoff CR, Mühleisen TW, Eickhoff SB, Nickl-Jockschat T.

Brain Struct Funct. 2018 Sep;223(7):3045-3061. doi: 10.1007/s00429-018-1670-9. Epub 2018 May 5.

PMID:
29730826
4.

Interaction between childhood adversity and functional polymorphisms in the dopamine pathway on first-episode psychosis.

Trotta A, Iyegbe C, Yiend J, Dazzan P, David AS, Pariante C, Mondelli V, Colizzi M, Murray RM, Di Forti M, Fisher HL.

Schizophr Res. 2018 Apr 10. pii: S0920-9964(18)30199-3. doi: 10.1016/j.schres.2018.04.010. [Epub ahead of print]

PMID:
29653893
5.

Longitudinal Analyses of Blood Transcriptome During Conversion to Psychosis.

Chaumette B, Kebir O, Pouch J, Ducos B, Selimi F; ICAAR study group, Gaillard R, Krebs MO.

Schizophr Bull. 2018 Feb 17. doi: 10.1093/schbul/sby009. [Epub ahead of print]

PMID:
29471546
6.

Accessing Gene Expression in Treatment-Resistant Schizophrenia.

Moretti PN, Ota VK, Gouvea ES, Pedrini M, Santoro ML, Talarico F, Spindola LM, Carvalho CM, Noto C, Xavier G, Brietzke E, Gadelha A, Bressan R, Mari J, Belangero S.

Mol Neurobiol. 2018 Aug;55(8):7000-7008. doi: 10.1007/s12035-018-0876-4. Epub 2018 Jan 26.

PMID:
29374346
7.

Gene-environment interplay in the etiology of psychosis.

Zwicker A, Denovan-Wright EM, Uher R.

Psychol Med. 2018 Sep;48(12):1925-1936. doi: 10.1017/S003329171700383X. Epub 2018 Jan 15.

PMID:
29334044
8.

The effect of interactions between genetics and cannabis use on neurocognition. A review.

Cosker E, Schwitzer T, Ramoz N, Ligier F, Lalanne L, Gorwood P, Schwan R, Laprévote V.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Mar 2;82:95-106. doi: 10.1016/j.pnpbp.2017.11.024. Epub 2017 Nov 28. Review.

PMID:
29191570
9.

Peripheral Transcription of NRG-ErbB Pathway Genes Are Upregulated in Treatment-Resistant Schizophrenia.

Mostaid MS, Lee TT, Chana G, Sundram S, Shannon Weickert C, Pantelis C, Everall I, Bousman C.

Front Psychiatry. 2017 Nov 6;8:225. doi: 10.3389/fpsyt.2017.00225. eCollection 2017.

10.

Correlation of DRD2 mRNA expression levels with deficit syndrome severity in chronic schizophrenia patients receiving clozapine treatment.

Liu L, Luo Y, Zhang G, Jin C, Zhou Z, Cheng Z, Yuan G.

Oncotarget. 2017 Sep 23;8(49):86515-86526. doi: 10.18632/oncotarget.21230. eCollection 2017 Oct 17.

11.

PKBγ/AKT3 loss-of-function causes learning and memory deficits and deregulation of AKT/mTORC2 signaling: Relevance for schizophrenia.

Howell KR, Floyd K, Law AJ.

PLoS One. 2017 May 3;12(5):e0175993. doi: 10.1371/journal.pone.0175993. eCollection 2017.

12.

Genetic Deletion of Akt3 Induces an Endophenotype Reminiscent of Psychiatric Manifestations in Mice.

Bergeron Y, Bureau G, Laurier-Laurin MÉ, Asselin E, Massicotte G, Cyr M.

Front Mol Neurosci. 2017 Apr 10;10:102. doi: 10.3389/fnmol.2017.00102. eCollection 2017.

13.

New Repeat Polymorphism in the AKT1 Gene Predicts Striatal Dopamine D2/D3 Receptor Availability and Stimulant-Induced Dopamine Release in the Healthy Human Brain.

Shumay E, Wiers CE, Shokri-Kojori E, Kim SW, Hodgkinson CA, Sun H, Tomasi D, Wong CT, Weinberger DR, Wang GJ, Fowler JS, Volkow ND.

J Neurosci. 2017 May 10;37(19):4982-4991. doi: 10.1523/JNEUROSCI.3155-16.2017. Epub 2017 Apr 17.

14.

BACE1-Deficient Mice Exhibit Alterations in Immune System Pathways.

Stertz L, Contreras-Shannon V, Monroy-Jaramillo N, Sun J, Walss-Bass C.

Mol Neurobiol. 2018 Jan;55(1):709-717. doi: 10.1007/s12035-016-0341-1. Epub 2016 Dec 21.

PMID:
28004339
15.

Gene expression alterations related to mania and psychosis in peripheral blood of patients with a first episode of psychosis.

Gouvea ES, Ota VK, Noto C, Santoro ML, Spindola LM, Moretti PN, Carvalho CM, Xavier G, Rios AC, Sato JR, Hayashi MA, Brietzke E, Gadelha A, Bressan RA, Cordeiro Q, Belangero SI.

Transl Psychiatry. 2016 Oct 4;6(10):e908. doi: 10.1038/tp.2016.159.

16.
17.

Cannabis and a lower BMI in psychosis: What is the role of AKT1?

Liemburg EJ, Bruins J, van Beveren N, Islam MA, Alizadeh BZ; GROUP investigators.

Schizophr Res. 2016 Oct;176(2-3):95-99. doi: 10.1016/j.schres.2016.08.014. Epub 2016 Aug 21.

PMID:
27554198
18.

Decreased VEGFR2 expression and increased phosphorylated Akt1 in the prefrontal cortex of individuals with schizophrenia.

Hino M, Kunii Y, Matsumoto J, Wada A, Nagaoka A, Niwa S, Takahashi H, Kakita A, Akatsu H, Hashizume Y, Yamamoto S, Yabe H.

J Psychiatr Res. 2016 Nov;82:100-8. doi: 10.1016/j.jpsychires.2016.07.018. Epub 2016 Jul 25.

PMID:
27484635
19.

The mRNA expression of DRD2, PI3KCB, and AKT1 in the blood of acute schizophrenia patients.

Liu L, Luo Y, Zhang G, Jin C, Zhou Z, Cheng Z, Yuan G.

Psychiatry Res. 2016 Sep 30;243:397-402. doi: 10.1016/j.psychres.2016.07.010. Epub 2016 Jul 5.

PMID:
27449010
20.

Genetic Association of TCF4 and AKT1 Gene Variants with the Age at Onset of Schizophrenia.

Chow TJ, Tee SF, Yong HS, Tang PY.

Neuropsychobiology. 2016;73(4):233-40. doi: 10.1159/000446285. Epub 2016 Jun 16.

PMID:
27305091

Supplemental Content

Loading ...
Support Center